ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,352.96
-0.02%
Dow Jones
38,886.17
0.00%
US Dollar vs MXN
17.87575
-0.06%
Brent Oil
80.245
0.46%
Bitcoin
71,503.72
1.05%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ContextLogic Inc (LOGC)

  7. ContextLogic Inc (LOGC) Noticias

LOGC

ContextLogic (LOGC)

ContextLogic Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LOGC
FechaHoraFuenteTítuloSímboloCompañía
10/02/202315:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOGCContextLogic Inc
29/11/202215:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LOGCContextLogic Inc
21/11/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOGCContextLogic Inc
16/11/202215:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202215:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOGCContextLogic Inc
16/11/202208:56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LOGCContextLogic Inc
16/11/202207:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOGCContextLogic Inc
16/11/202207:21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOGCContextLogic Inc
14/11/202207:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LOGCContextLogic Inc
14/11/202207:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
14/11/202207:00PR Newswire (US)LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:LOGCContextLogic Inc
20/10/202207:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOGCContextLogic Inc
18/10/202215:14Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LOGCContextLogic Inc
18/10/202215:04Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LOGCContextLogic Inc
13/10/202215:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LOGCContextLogic Inc
03/10/202215:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LOGCContextLogic Inc
03/10/202210:20Dow Jones NewsLogicBio Therapeutics Shares Soar on Takeover by AstraZenecaNASDAQ:LOGCContextLogic Inc
03/10/202209:50TipRanksAnalysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
03/10/202207:19TipRanksAstraZeneca to Buy LogicBio Therapeutics for $2.07 Per ShareNASDAQ:LOGCContextLogic Inc
03/10/202206:57Dow Jones NewsAstraZeneca to Buy LogicBio Therapeutics for $68 MillionNASDAQ:LOGCContextLogic Inc
03/10/202206:15Business WireAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
21/09/202207:30PR Newswire (US)LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONENASDAQ:LOGCContextLogic Inc
18/08/202221:15TipRanksLogicbio Therapeutics (LOGC) Receives a Buy from William BlairNASDAQ:LOGCContextLogic Inc
16/08/202203:55TipRanksJMP Securities Keeps Their Buy Rating on Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
15/08/202206:05PR Newswire (US)LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:LOGCContextLogic Inc
21/06/202207:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOGCContextLogic Inc
24/05/202204:06TipRanksWilliam Blair Thinks Logicbio Therapeutics’ Stock is Going to RecoverNASDAQ:LOGCContextLogic Inc
18/05/202206:40TipRanksAnalysts Offer Insights on Healthcare Companies: Compugen (CGEN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
17/05/202223:45TipRanksAnalysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
17/05/202207:30PR Newswire (US)LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:LOGCContextLogic Inc
 Showing the most relevant articles for your search:NASDAQ:LOGC

Su Consulta Reciente

NYSE
NKE
Nike
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
FX
EURMXN
Euro vs MXN
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
NYSE
AXP
American Express
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados